Hypertension Trial, Recruiting NCT06917131 Sponsor: Universidade Federal Fluminense Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT06917131
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with stage 1 high blood pressure (the early, milder stage of high blood pressure)
  • People who have been receiving regular treatment for their high blood pressure for more than 6 months
  • People whose blood pressure medication doses have not changed in the last 3 months

Who may not be able to join:

  • People who have an autoimmune disease (conditions where the immune system attacks the body)
  • People who have an active infectious disease
  • People who have diabetes
  • People who have chronic kidney disease
  • People who have liver disease
  • People who have cancer
  • People who have AIDS
  • People who are pregnant
  • People who are currently taking catabolic drugs (medications that break down body tissue) or antibiotics
  • People who are currently taking antioxidant vitamin supplements, prebiotics, probiotics, or synbiotics (certain gut or digestive health supplements)
  • People who regularly consume royal jelly (a substance produced by bees)
  • People who have an allergy to bee stings
  • People who have recently had a heart attack
  • People who have recently had a stroke

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ludmila Cardozo, PhD, Universidade Federal Fluminense

Phone: +5521985683003

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universidade Federal Fluminense
Registry
ClinicalTrials.gov
Start date
18 September 2024
Est. completion
10 December 2026

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Change of inflammatory transcripton factor

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov